CRISPR THERAPEUTICS AG (CRSP)
CH0334081137 - Common Stock
ChartMill assigns a Buy % Consensus number of 74% to CRSP. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 81.64. This target is 101.69% above the current price.
CRSP was analyzed by 35 analysts. The buy percentage consensus is at 74. So analysts seem to be have mildly positive about CRSP.
In the previous month the buy percentage consensus was at a similar level.
CRSP was analyzed by 35 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-12-20 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-12-10 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-11-06 | Needham | Reiterate | Buy -> Buy |
| 2024-11-06 | RBC Capital | Reiterate | Sector Perform -> Sector Perform |
| 2024-11-06 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2024-10-04 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2024-08-12 | Truist Securities | Maintains | Buy -> Buy |
| 2024-08-08 | Cantor Fitzgerald | Reiterate | Neutral |
| 2024-08-06 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-08-06 | Needham | Maintains | Buy -> Buy |
| 2024-08-06 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2024-08-06 | Stifel | Maintains | Hold -> Hold |
| 2024-08-06 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2024-06-27 | Needham | Reiterate | Buy -> Buy |
| 2024-06-17 | Needham | Reiterate | Buy -> Buy |
| 2024-06-17 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2024-05-23 | Citigroup | Maintains | Buy -> Buy |
| 2024-05-10 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-05-09 | Cantor Fitzgerald | Reiterate | Neutral |
| 2024-05-09 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-05-09 | Needham | Maintains | Buy -> Buy |
| 2024-05-09 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2024-05-09 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2024-05-09 | Baird | Maintains | Neutral -> Neutral |
| 2024-04-18 | Citigroup | Maintains | Buy -> Buy |
| 2024-04-11 | Needham | Reiterate | Buy -> Buy |
| 2024-03-06 | Mizuho | Maintains | Buy -> Buy |
| 2024-02-26 | Morgan Stanley | Maintains | Underweight -> Underweight |
| 2024-02-22 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-02-22 | RBC Capital | Maintains | Sector Perform -> Sector Perform |